Literature DB >> 3297896

Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus.

S Sjöberg, R Gunnarsson, M Gjötterberg, A K Lefvert, A Persson, J Ostman.   

Abstract

The aim of the present study was to evaluate the role of residual insulin production in long-term Type 1 (insulin-dependent) diabetes mellitus. Ninety-seven patients with a disease duration of 9-16 years and onset before the age of 30 years were studied. C-peptide excretion in 24-h urine samples was measured as an indicator of residual insulin production. Thirty-five patients (36%) excreted C-peptide (greater than or equal to 0.2 nmol); as many as possible of them were carefully matched with a non-excretor patient with regard to age at onset of diabetes and disease duration. Twenty-nine pairs were obtained, and 22 of them agreed to participate in further investigations of glycaemic control and microangiopathic lesions. The patients who excreted C-peptide had significantly lower HbA1c than the non-excretor group, 6.9 +/- 0.3% vs 7.9 +/- 0.3%, (p less than 0.025). Moderate-to-advanced background retinopathy was found in 2 patients in the excretor group and in 7 patients in the non-excretor group. Microalbuminuria [ratio of albumin: creatinine (mg/l:mmol/l) greater than or equal to 5] was found in 1 and in 5 patients, respectively, while proteinuria [ratio of protein: creatinine (mg/l:mmol/l X 10) greater than or equal to 136] was found in 0 and in 4 patients, respectively. Microalbuminuria and/or proteinuria was found in 7 of the non-excretor group as compared to 1 in the excretor group (p = 0.046).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297896     DOI: 10.1007/BF00270417

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Editorial: Lysozyme.

Authors:  E F Osserman
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

2.  B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment.

Authors:  O K Faber; C Binder
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

3.  Catabolsm of human beta-2-microglobulin by the rat kidney.

Authors:  G M Bernier; M E Conrad
Journal:  Am J Physiol       Date:  1969-11

4.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

5.  Prognosis of alcoholic peripheral neuropathy.

Authors:  M Hillbom; A Wennberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

6.  Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.

Authors:  S Sjöberg; R Gunnarsson; J Ostman
Journal:  Acta Med Scand       Date:  1983

7.  R-R variations, a test of autonomic dysfunction.

Authors:  A Persson; G Solders
Journal:  Acta Neurol Scand       Date:  1983-05       Impact factor: 3.209

8.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

9.  Residual insulin secretion in insulin dependent diabetes mellitus.

Authors:  S Rogers; M Silink
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

10.  Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.

Authors:  B Marner; T Agner; C Binder; A Lernmark; J Nerup; T Mandrup-Poulsen; S Walldorff
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

View more
  36 in total

1.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

2.  Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes.

Authors:  Heba M Ismail; Carmella Evans-Molina; Linda A DiMeglio; Dorothy J Becker; Ingrid Libman; Emily K Sims; David Boulware; Kevan C Herold; Lisa Rafkin; Jay Skyler; Mario A Cleves; Jerry Palmer; Jay M Sosenko
Journal:  Pediatr Diabetes       Date:  2019-04-15       Impact factor: 4.866

3.  Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.

Authors:  T Forst; T Kunt; T Pohlmann; K Goitom; M Engelbach; J Beyer; A Pfützner
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 4.  Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a review.

Authors:  Naomi Achong; Harold David McIntyre; Leonie Callaway
Journal:  Obstet Med       Date:  2014-01-17

5.  Effect of cyclosporin A on B-cell loss in type 1 (insulin-dependent) diabetes mellitus.

Authors:  P Vague; B Vialettes; R Picq; S Dol; V Lassmann-Vague
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

Review 6.  Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.

Authors:  Ahmad Ghorbani; Reza Shafiee-Nick
Journal:  World J Diabetes       Date:  2015-02-15

7.  The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients.

Authors:  B L Johansson; S Sjöberg; J Wahren
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

8.  Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).

Authors:  P Pozzilli; N Visalli; A Signore; M G Baroni; R Buzzetti; M G Cavallo; M L Boccuni; D Fava; C Gragnoli; D Andreani
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

9.  Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; B L Johansson; J Ostman; J Wahren
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

10.  Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.

Authors:  Sergio A Dib; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-12-04       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.